GLPwatch
Papers (10404)
Page 81 of 174, ranked by citation count.
- Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus.
- Simultaneous angiotensin receptor blockade and glucagon-like peptide-1 receptor activation ameliorate albuminuria in obese insulin-resistant rats.
- Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment.
- Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists.
- Semaglutide in renal ischemia-reperfusion injury in mice.
- Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide.
- Semaglutide in Psychiatry-Opportunities and Challenges.
- Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial.
- Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y<sub>2</sub> Receptor Agonists.
- Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.
- Liraglutide: effects beyond glycaemic control in diabetes treatment.
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
- Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study.
- Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin.
- Site-selective modification of exendin 4 with variable molecular weight dextrans by oxime-ligation chemistry for improving type 2 diabetic treatment.
- 68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders.
- What is the evidence regarding the safety of new obesity pharmacotherapies.
- Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes.
- Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
- A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
- Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature.
- Evaluating the usability and safety of the semaglutide single-dose pen-injectors through summative (human factors) usability testing.
- Semaglutide and the future of obesity care in the UK.
- Optimization of pig models for translation of subcutaneous pharmacokinetics of therapeutic proteins: Liraglutide, insulin aspart and insulin detemir.
- Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report.
- PEGDA/HA mineralized hydrogel loaded with Exendin4 promotes bone regeneration in rat models with bone defects by inducing osteogenesis.
- Comparative Efficacy of Glucagon-like Peptide 1 Receptor Agonists and Sodium Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular Events in Type 2 Diabetes: A Network Meta-analysis.
- The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.
- Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes.
- Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c‑JUN signaling pathway.
- One-year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes.
- The inhibitory effects of Dulaglutide on cellular senescence against high glucose in human retinal endothelial cells.
- The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype.
- The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan.
- Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.
- Semaglutide versus other GLP-1 receptor agonists in patients with MASLD.
- No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery.
- Comparison of weight loss and adverse events of obesity drugs in children and adolescents: a systematic review and meta-analysis.
- Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m<sup>2</sup>, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial.
- Medical and surgical treatment of postbariatric hypoglycaemia: Retrospective data from daily practice.
- Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach.
- Effect of hydroxyethyl starch on drug stability and release of semaglutide in PLGA microspheres.
- Cost-effectiveness of second-line empagliflozin versus liraglutide for type 2 diabetes in the United States.
- Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports.
- Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy.
- Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction.
- Semaglutide for Weight Loss: Was It Worth the Weight?
- Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial.
- Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats.
- Effects of liraglutide and ischemic postconditioning on myocardial salvage after I/R injury in pigs.
- Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism.
- Up and down waves of glycemic control and lower-extremity amputation in diabetes.
- Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.
- The Effects of Exenatide Microsphere on Serum BGP and ALP Levels in ZDF Rats after Implantation.
- Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus.
- Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.
- Exendin-4 increases absence-like seizures and anxiety-depression-like behaviors in WAG/Rij rats.
- High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management.
- Real-World Hemoglobin A1c Changes, Prescribing Provider Types, and Medication Dose Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide.